Apo-Lisdexamfetamine 30mg : may contain broken capsules and/or loose capsule content.
Brand(s)
Last updated
Summary
Product
Apo-Lisdexamfetamine 30mg
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Apotex | Apo-Lisdexamfetamine | DIN 02546663 | Capsules | LISDEXAMFETAMINE DIMESYLATE 30mg | VJ8877 |
Issue
Affected lot may contain broken capsules and/or loose capsule content.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers & Pharmacies
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Biologic or vaccine
Companies
Apotex Inc.
150 Signet Drive
Toronto, ON
M9L 1T9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-77761
Get notified
Receive notifications for new and updated recalls and alerts by category.